Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Fujita T, Inoue K, Yamamoto S, Ikumoto S, Sasaki S, Toyama R, Chiba K, Hoshino Y, Okumoto T (1994) Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclarii metabolite. Journal of Antibiotics (Tokyo) 47: 208–215
Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch K-W, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nature Medicine 8: 128–135
Korff T, Augustin HG (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. Journal of Cell Biology 143: 1341–1352
Schmid G, Guba M, Papyan A, Ischenko I, Brueckel M, Bruns CJ, Jauch K-W, Graeb C (2005) FTY720 inhibits tumor growth and angiogenesis. Transplantation Proceedings 37: 110–111
Tanaka T, Takahara S, Hatori M, Suzuki K, Wang J, Ichimaru N, Suzuki S, Morozumi K, Okuyama A, Yamanaka H (2002) A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine. Cancer Letters 181: 165–171
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this paper
Cite this paper
Schmid, G. et al. (2006). Anti-tumorigene und anti-angiogenetische Wirkung des Immunsuppressivums FTY720. In: Saeger, H.D., Jauch, K.W., Bauer, H. (eds) Chirurgisches Forum 2006. Deutsche Gesellschaft für Chirurgie, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-34668-6_20
Download citation
DOI: https://doi.org/10.1007/3-540-34668-6_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-32480-5
Online ISBN: 978-3-540-34668-5
eBook Packages: Medicine (German Language)